LAVA Therapeutics NV
LVTX1.485USD
+0.015+1.02%
收盘 09/19, 16:00（美东）报价延迟15分钟
39.06M总市值
亏损市盈率 TTM
关于 LAVA Therapeutics NV 公司
LAVA Therapeutics NV 前身为 Lava Therapeutics BV，是一家总部位于荷兰的生物技术研发服务提供商。该公司专注于开发下一代 Vdelta T 细胞结合双特异性抗体来对抗癌症。
公司简介
公司代码LVTX
公司名称LAVA Therapeutics NV
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
员工数量34
证券类型Ordinary Share
年结日Mar 25
公司地址Yalelaan 60
城市UTRECHT
上市交易所NASDAQ Global Select Consolidated
国家Netherlands
邮编3584 CM
电话31630003035
网址https://www.lavatherapeutics.com/
公司代码LVTX
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Hans Van Der Vliet, M.D., Ph.D.
Mr. Hans Van Der Vliet, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
77.35K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
30.00K
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
10.00K
--
Ms. Amy Garabedian
Ms. Amy Garabedian
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
8.85K
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stephen A. Hurly
Mr. Stephen A. Hurly
President, Chief Executive Officer, Management Director
President, Chief Executive Officer, Management Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Hans Van Der Vliet, M.D., Ph.D.
Mr. Hans Van Der Vliet, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
77.35K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
30.00K
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
10.00K
--
Ms. Amy Garabedian
Ms. Amy Garabedian
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
8.85K
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月6日 周六
更新时间: 9月6日 周六
持股股东
股东类型
持股股东
持股股东
占比
Cooperatieve Gilde Healthcare IV UA
20.61%
Versant Ventures
11.04%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi SA
7.30%
其他
45.68%
持股股东
持股股东
占比
Cooperatieve Gilde Healthcare IV UA
20.61%
Versant Ventures
11.04%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi SA
7.30%
其他
45.68%
股东类型
持股股东
占比
Corporation
32.27%
Venture Capital
11.04%
Investment Advisor
10.30%
Investment Advisor/Hedge Fund
7.94%
Individual Investor
1.28%
Hedge Fund
0.48%
Research Firm
0.23%
其他
36.46%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
48
18.32M
69.64%
-2.74M
2025Q1
59
22.25M
84.60%
-1.27M
2024Q4
61
18.80M
71.50%
-11.80K
2024Q3
56
15.93M
60.60%
-3.34M
2024Q2
58
16.07M
61.13%
-4.19M
2024Q1
58
16.06M
61.10%
-4.38M
2023Q4
51
18.10M
68.85%
+283.15K
2023Q3
52
18.00M
68.48%
-418.56K
2023Q2
55
18.03M
68.58%
-1.16M
2023Q1
60
19.21M
73.06%
-886.64K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Cooperatieve Gilde Healthcare IV UA
5.42M
20.61%
--
--
Mar 31, 2025
Versant Ventures
4.59M
17.44%
--
--
Mar 31, 2025
Redmile Group, LLC
2.07M
7.89%
--
--
Mar 31, 2025
BML Capital Management LLC
1.96M
7.45%
+2.50K
+0.13%
Mar 31, 2025
Sanofi SA
1.92M
7.3%
+1.92M
--
Dec 31, 2024
Merck & Co Inc
1.15M
4.37%
--
--
Mar 31, 2025
Bruce & Company, Inc.
521.87K
1.98%
-250.00K
-32.39%
Mar 31, 2025
Pathway Financial Advisors, LLC
102.50K
0.39%
--
--
Mar 31, 2025
Powell (Fred M)
65.00K
0.25%
-7.56K
-10.42%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
